Onyx Biotec

ONYX

Q: Is the debt of Onyx Biotec increasing or decreasing?

Yes, The net debt of Onyx Biotec is increasing.Latest net debt of Onyx Biotec is ₹8.54 Crs as of Sep-25.This is greater than Mar-25 when it was -₹4.59 Crs.

Q: Is Onyx Biotec stock expensive?

Onyx Biotec is not expensive.Latest PE of Onyx Biotec is 12.99, while 3 year average PE is 24.55. Also latest EV/EBITDA of Onyx Biotec is 6.01 while 3yr average is 9.42.

Price

Nano Cap

₹56 Cr.

New to Zerodha? Sign-up for free.

Onyx Biotec specializes in manufacturing pharmaceutical products like sterile water ampoule, dry injection, and dry syrup. Their products adhere to global FDA practices, undergo rigorous testing in FDA Certified Laboratories, and maintain international quality standards. The company's core focus is on offering comprehensive product development and manufacturing services to clients. Less

Onyx Biotec specializes in manufacturing pharmaceutical products like sterile water ampoule, dry in… More

Low

28.10

52W Range

High

62.45

11.27

Sector PE

26.27

P/B

1.01

Div.Yield

ROE

8.91%

EBIDTA

5.3

ROCE

12.96

EPS

New to Zerodha? Sign-up for free.

Get instant stock alerts

Share Price
Financials
Revenue mix
Shareholdings
Peers
Forensics

Coming soon

Summary
Profit & Loss
Balance sheet
Cashflow

Yearly | Quarterly

View Detailed Summary

This data is currently unavailable for this company.

Yearly | Quarterly

(In Cr.)

(In Cr.)
This data is currently unavailable for this company.

Financial Ratio's

(In %)

Detailed P&L Report

(In Cr.)

Detailed Balance Sheet

Financial Year (In Cr.)

Detailed Cash Flow

Product wise
Location wise

ONYX
Revenue Mix

Latest

Historic

This data is currently unavailable for this company.

ONYX
Revenue Mix

Latest

Historic

This data is currently unavailable for this company.

More Info

Shareholdings

Holders

Detailed Shareholdings

This data is currently unavailable for this company.

Peers

Detailed Peers

Forensics

View Detailed Forensics

Recent events

News
Corporate Actions

Onyx Biotec Enters Agreement With Galpha Laboratories For Dry Powder Injection

Apr 24, 2025

Onyx Biotec Enters Agreement With Galpha Laboratories

Apr 08, 2025

Onyx Biotec Says Mankind Pharma Completes Audit Of Dry Powder Injection

Dec 26, 2024

Events:

Quarterly Results

Announcement Date

Nov 13, 2025

Quarterly Results

Announcement Date

May 28, 2025

Quarterly Results

Announcement Date

Jan 10, 2025

More Nano Cap Ideas

See similar 'Nano' cap companies with recent activity

Promoter Buying

Companies where the promoters are bullish

Detailed List

Capex

Companies investing on expansion

Detailed List

Superstar Investor

Companies where well known investors have invested

Detailed List

Popular questions

Business
Financials
Share Price
Shareholdings

What does Onyx Biotec do?

Onyx Biotec is engaged in the business of Manufacturing of Pharmaceutical Products such as sterile water ampoule, dry injection, dry syrup etc. Its products are being processed and manufactured in accordance with best Food and Drug Administration (FDA) practices available globally. Its system and product are tested constantly at each level to ensure international standards of quality in-house and FDA Certified Laboratories. Its core business is focused on providing end-to-end product development and manufacturing solutions to its clients.

Who are the competitors of Onyx Biotec?

Onyx Biotec major competitors are Cohance Lifesciences, JB Chem & Pharma, Vivimed Labs, Phaarmasia, Vineet Laboratories, Godavari Drugs, Vivo Bio Tech. Market Cap of Onyx Biotec is ₹64 Crs. While the median market cap of its peers are ₹61 Crs.

Is Onyx Biotec financially stable compared to its competitors?

Onyx Biotec seems to be less financially stable compared to its competitors. Altman Z score of Onyx Biotec is 2.87 and is ranked 4 out of its 8 competitors.

Does Onyx Biotec pay decent dividends?

The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Onyx Biotec latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

How has Onyx Biotec allocated its funds?

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments, Inventory

How strong is Onyx Biotec balance sheet?

Balance sheet of Onyx Biotec is moderately strong.

Is the profitablity of Onyx Biotec improving?

The profit is oscillating. The profit of Onyx Biotec is ₹1.07 Crs for TTM, ₹4.95 Crs for Mar 2025 and ₹3.63 Crs for Mar 2024.

Is the debt of Onyx Biotec increasing or decreasing?

Yes, The net debt of Onyx Biotec is increasing. Latest net debt of Onyx Biotec is ₹8.54 Crs as of Sep-25. This is greater than Mar-25 when it was -₹4.59 Crs.

Is Onyx Biotec stock expensive?

Onyx Biotec is not expensive. Latest PE of Onyx Biotec is 12.99, while 3 year average PE is 24.55. Also latest EV/EBITDA of Onyx Biotec is 6.01 while 3yr average is 9.42.

Has the share price of Onyx Biotec grown faster than its competition?

Onyx Biotec has given lower returns compared to its competitors. Onyx Biotec has grown at ~-39.69% over the last 1yrs while peers have grown at a median rate of -15.06%

Is the promoter bullish about Onyx Biotec?

Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Onyx Biotec is 65.1% and last quarter promoter holding is 65.1%.

Are mutual funds buying/selling Onyx Biotec?

There is Insufficient data to gauge this.

ONYX

Share Price

Financials

Summary

Profit & Loss

Balance sheet

Cashflow

Revenue mix

Product wise

Location wise

Shareholdings

Peers

Forensics

Recent events

News

Corporate Actions

Onyx Biotec Enters Agreement With Galpha Laboratories For Dry Powder Injection

Onyx Biotec Enters Agreement With Galpha Laboratories

Onyx Biotec Says Mankind Pharma Completes Audit Of Dry Powder Injection

Events:

Quarterly Results

Quarterly Results

Quarterly Results

More Nano Cap Ideas

Promoter Buying

Capex

Superstar Investor

Popular questions

Business

Financials

Share Price

Shareholdings

What does Onyx Biotec do?

Who are the competitors of Onyx Biotec?

Is Onyx Biotec financially stable compared to its competitors?

Does Onyx Biotec pay decent dividends?

How has Onyx Biotec allocated its funds?

How strong is Onyx Biotec balance sheet?

Is the profitablity of Onyx Biotec improving?

Is the debt of Onyx Biotec increasing or decreasing?

Is Onyx Biotec stock expensive?

Has the share price of Onyx Biotec grown faster than its competition?

Is the promoter bullish about Onyx Biotec?

Are mutual funds buying/selling Onyx Biotec?